Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy

Figure 1

The time axis presenting dates of FDA (US Food and Drug Administration) and EMA (European Medicines Agency) approval of novel agents for advanced melanoma treatment.